The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 328:1213-1219 April 29, 1993 Number 17
NextNext

The Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with Hypercholesterolemia
Donald B. Hunninghake, Evan A. Stein, Carlos A. Dujovne, William S. Harris, Elaine B. Feldman, Valery T. Miller, Jonathan A. Tobert, Peter M. Laskarzewski, Elaine Quiter, Jolene Held, Alice M. Taylor, Suzanne Hopper, Sandra B. Leonard, and Brenda K. Brewer

 Sign up for free e-toc
 

This Article
-Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background A diet low in saturated fat and cholesterol is the standard initial treatment for hypercholesterolemia. However, little quantitative information is available about the efficacy of dietary therapy in clinical practice or about the combined effects of diet and drug therapy.

Methods One hundred eleven outpatients with moderate hypercholesterolemia were treated at five lipid clinics with the National Cholesterol Education Program Step 2 diet (which is low in fat and cholesterol) and lovastatin (20 mg once daily), both alone and together. A diet high in fat and cholesterol and a placebo identical in appearance to the lovastatin were used as the respective controls. Each of the 97 patients completing the study (58 men and 39 women) underwent four consecutive nine-week periods of treatment according to a randomized, balanced design: a high-fat diet-placebo period, a low-fat diet-placebo period, a high-fat diet-lovastatin period, and a low-fat diet-lovastatin period.

Results The level of low-density lipoprotein (LDL) cholesterol was a mean of 5 percent (95 percent confidence interval, 3 to 7 percent) lower during the low-fat diet than during the high-fat diet (P<0.001). With lovastatin therapy as compared with placebo, the reduction was 27 percent. Together, the low-fat diet and lovastatin led to a mean reduction of 32 percent in the level of LDL cholesterol. The level of high-density lipoprotein (HDL) cholesterol fell by 6 percent (95 percent confidence interval, 4 to 8 percent) during the low-fat diet (P<0.001) and rose by 4 percent during treatment with lovastatin (P<0.001). The ratio of LDL to HDL cholesterol and the level of total triglycerides were reduced by lovastatin (P<0.001), but not by the low-fat diet.

Conclusions The effects of the low-fat-low-cholesterol diet and lovastatin on lipoprotein levels were independent and additive. However, the reduction in LDL cholesterol produced by the diet was small, and its benefit was possibly offset by the accompanying reduction in the level of HDL cholesterol.


Source Information

From the Heart Disease Prevention Clinic, Minneapolis (D.B.H., E.Q.); the Christ Hospital Cardiovascular Research Center, Cincinnati (E.A.S., S.H.); the University of Kansas Medical Center, Kansas City (C.A.D., W.S.H.); the Medical College of Georgia, Augusta (E.B.F., S.B.L.); George Washington University, Washington, D.{beta}(V.T.M., B.K.B.); Merck Research Laboratories, Rahway, N.J. (J.A.T., A.M.T.); Medical Research Laboratories, Cincinnati (P.M.L.); and Professional Nutrition Systems, Kansas City, Kans. (J.H.). The following persons also participated in the study: Heart Disease Prevention Clinic, Minneapolis -- J. Peters and K. Gardner; Christ Hospital Cardiovascular Research Center, Cincinnati -- D.M. Black, G.E. Lamkin, and S. Ames; University of Kansas Medical Center, Kansas City -- P. Krehbiel and S. Horniman; Medical College of Georgia, Augusta -- T.T. Kuske and J.M. Greene; George Washington University, Washington, D.{beta} -- D.B. Stoy and G. Gasparis; and Medical Research Laboratories, Cincinnati -- P.M. Steiner.

Address reprint requests to Dr. Hunninghake at the Heart Disease Prevention Clinic, 151 Variety Club Heart & Research Center, 401 E. River Rd., Minneapolis, MN 55455.

Full Text of this Article


Related Letters:

Treatment of and Screening for Hyperlipidemia
Ornish D., Brown S. E., Kottke B. A., Shea S., Barth J. D., Bryan G. K., Hokanson J. E., Austin M. A., Ginsberg H. N., Tall A. R., Deckelbaum R. J., Hunninghake D. B., Criqui M. H., Heiss G., Sox H. C.
Extract | Full Text  
N Engl J Med 1993; 329:1124-1128, Oct 7, 1993. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.